Michael Doe's Album: Wall Photos

Photo 2 of 4 in Wall Photos

The contract fill /
finish services market for biologics is anticipated to be worth USD 4.2
billion by 2030.







A steadily growing demand for biologic fill / finish
services has generated a range of new opportunities for contract service
providers; stakeholders have invested heavily to ensure product integrity and
safety





Roots Analysis is pleased to announce the publication of its recent study,
titled, “Biologics Fill /
Finish Services Market, 2019-2030.”





The report features an extensive study on the contract
service providers offering drug product manufacturing services within the
biopharmaceutical industry. The study features in-depth analysis, highlighting
the capabilities of a diverse set of companies that claim to specialize in fill
/ finish operations. Amongst other elements, the report includes:


§
A detailed review of the overall landscape of contract fill
/ finish services market for biopharmaceuticals.


§
A region-wise, company competitiveness analysis,
highlighting prominent fill / finish service providers across various packaging
types.


§
Elaborate profiles of key players across key geographies
(North America, Europe and Asia-Pacific).


§
An analysis of the recent collaborations (signed since
2013) focused on the contract fill / finish services for biologics.


§
A detailed analysis of the expansions undertaken (since
2013) by various service providers for augmenting their respective fill /
finish service portfolios.


§
An estimate of the global contract fill / finish capacity,
by taking into consideration the capacities of various fill / finish service
providers.


§
An informed estimate of the annual demand for fill / finish
of biologics, taking into account the top 20 biologics.


§
An analysis to identify the key performance indicators for
service providers active in the domain.


§
A case study to highlight the benefits of using robotic /
automated equipment for aseptic fill / finish processes.


§
A case study to highlight the role of ready-to-use
packaging containers in aseptic fill / finish operations.


§
A discussion on the potential growth areas and recent trends
impacting the outsourcing potential for biopharmaceuticals.


§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)





To request for sample report - https://www.rootsanalysis.com/reports/256/request-sample.html





§ Types of Primary Packaging Containers


§ Ampoules


§ Cartridges


§ Syringes


§ Vials


§ Types of Biologics


§ Peptides / proteins


§ Antibodies


§ Vaccines


§ Cell therapies


§ Gene therapies


§ Viral products


§ Oligonucleotides


§ Others





§ Company Size


§ Small-sized


§ Mid-sized


§ Large / very large





§ Scale of Operation


§ Preclinical


§ Clinical


§ Commercial





§ Key Therapeutic Areas


§ Cancer


§ Infectious diseases


§ Autoimmune diseases


§ Cardiovascular diseases


§ Other indications





§ Key Geographical Regions


§ North America (US, Canada)


§ Europe (UK, France, Germany, Italy, Spain and
rest of the Europe)


§ Asia-Pacific (Japan, China, South Korea, India
and Australia)





The report features
inputs from a number of eminent industry stakeholders, according to whom,
“Currently, majority of biologics are being filled in vials, however, the
scenario is likely to change in the future due to the growing demand and
preference for self-administration devices.” The report features detailed
transcripts of discussions held with the following experts:


§
Ales Sima, Business Development Manager,
oncomed manufacturing


§
Gregor Kawaletz, Chief Commercial Officer,
IDT Biologika


§
Jos Vergeest, International Business
Developer, HALIX


§
Purushottam Singnurkar, Research Director
and Head of Formulation Development, Syngene International





Key
companies covered in the report


§ Advanced BioScience Laboratories (ABL)


§ Albany Molecular Research (AMRI)


§ Biocon


§ BioPharma Solutions


§ BioReliance


§ Boehringer Ingelheim BioXcellence


§ ChemPartner


§ Emergent BioSolutions


§ IDT Biologika


§ Lonza


§ LuinaBio


§ Mycenax Biotech


§ Patheon


§ Recipharm


§ Vetter Pharma


§ WuXi Biologics





For
more information please click on the following link:


https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html





Other Recent Offerings


1.
Vaccine Contract Manufacturing Market (2nd
Edition), 2019-2030


2.
Medical Device Contract Manufacturing Market,
2019-2030


3.
Elastomeric Closure Components Market For
Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields,
Plungers, Stoppers, Seals, Tip Caps and Other Closures


4.
Biopharma Contract Manufacturing Market (3rd
Edition), 2019 - 2030


5.
Patient Recruitment and Retention Services
Market, 2019-2030


About Roots Analysis


Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com





Contact Information


Roots
Analysis Private Limited


Gaurav Chaudhary


+1 (415) 800 3415


ben.johnson@rootsanalysis.com


Facebook - https://www.facebook.com/RootsAnalysis


LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/


Twitter - https://twitter.com/RootsAnalysis